Squizzato, Alessandro
Galliazzo, Silvia
Rancan, Elena
Di Pilla, Marina
Micucci, Giorgia
Podda, Gianmarco
Valeriani, Emanuele
Campiotti, Leonardo
Bertù, Lorenza
Ageno, Walter
Porreca, Ettore
Lodigiani, Corrado
Funding for this research was provided by:
Università degli Studi dell'Insubria
Article History
Received: 25 November 2020
Accepted: 21 May 2021
First Online: 10 June 2021
Declarations
:
: Alessandro Squizzato has received fees for lectures and advisory board meetings from Daiichi Sankyo, Pfizer, Bristol Myers Squibb, Bayer, Sanofi, and Techdow. Silvia Galliazzo has received fees for lectures by Daiichi Sakyo. Walter Ageno has received honoraria from Boehringer Ingelheim, Bayer Pharmaceuticals, BMS-Pfizer, Sanofi, Aspen, Portola, and Daiichi-Sankyo and research support from Bayer. Corrado Lodigiani has received fees for lectures from Daiichi Sankyo, Bayer, Boehringer Ingheleim, Pfizer, and Bristol Myers Squibb.
: The Medical Ethical Committee of Varese approved protocol on the 27th of Sep 2016.
: The Medical Ethical Committee of Varese approved the protocol on 27th September, 2016.
: Authorization to process data has been obtained when feasible.